Data as of Dec 19
| -0.85 / -0.50%|
The 16 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 200.00, with a high estimate of 213.00 and a low estimate of 162.00. The median estimate represents a +18.32% increase from the last price of 169.03.
The current consensus among 16 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.